NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

Generic Utilization Rates, Real Pharmaceutical Prices, and Research and Development Expenditures

Joseph P. Cook, Graeme Hunter, John A. Vernon

NBER Working Paper No. 15723
Issued in February 2010

---- Acknowledgements -----

Corresponding author: John A. Vernon, Department of Health Policy and Management, University of North Carolina at Chapel Hill and National Bureau of Economic Research. Email: vernon@email.unc.edu. We owe our greatest debt of gratitude to Ernie Berndt, who meticulously reviewed the current paper, and several revisions, and offered a great many helpful comments that improved the paper considerably. The authors are also grateful to a number of other individuals for their comments on this paper, and an earlier paper—upon which much of the current research builds. In particular, we thank: Carmelo Giaccotto, Joe Golec, Richard Manning, Gary Persinger, James Poterba, Rex Santerre, F.M. Scherer, John M. Vernon, and Kimberly Westrich. We are also very grateful to Nathan Blalock for research support and data work and Miguel Katigbak for help with the data. We thank the National Pharmaceutical Council for financial support for this study. The authors are also grateful to a number of other individuals for their comments on this paper, and an earlier paper—upon which much of the current research builds. In particular, we thank: Carmelo Giaccotto, Joe Golec, Richard Manning, Gary Persinger, Rex Santerre, F.M. Scherer, John M. Vernon, and Kimberly Westrich. We thank the National Pharmaceutical Council for financial support for this study. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.

return to bibliography page

 
Publications
Activities
Meetings
Data
People
About

Support
National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us